SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-045683
Filing Date
2023-02-23
Accepted
2023-02-23 08:10:32
Documents
13
Period of Report
2023-02-23
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d470699d8k.htm   iXBRL 8-K 24268
2 EX-99.1 d470699dex991.htm EX-99.1 103754
  Complete submission text file 0001193125-23-045683.txt   264512

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bxrx-20230223.xsd EX-101.SCH 2857
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bxrx-20230223_lab.xml EX-101.LAB 17979
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bxrx-20230223_pre.xml EX-101.PRE 11263
7 EXTRACTED XBRL INSTANCE DOCUMENT d470699d8k_htm.xml XML 3368
Mailing Address 490 LAPP ROAD MALVERN PA 19355
Business Address 490 LAPP ROAD MALVERN PA 19355 484-395-2470
Baudax Bio, Inc. (Filer) CIK: 0001780097 (see all company filings)

IRS No.: 474639500 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39101 | Film No.: 23656023
SIC: 8090 Services-Misc Health & Allied Services, NEC